ADDvise Group (OM:ADDV A) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

ADDV A Aktienübersicht

ADDvise Group AB (publ) liefert Geräte an Gesundheits- und Forschungseinrichtungen im privaten und öffentlichen Sektor in Schweden, dem übrigen Europa, Nordamerika, Afrika und Asien.

Über das Unternehmen

ADDV A fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	2/6
Financial Health	3/6
Dividends	0/6

Belohnungen

54.2% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 18.32% pro Jahr

Risikoanalyse

Die Verschuldung ist durch den operativer Cashflow nicht gut gedeckt

Die Aktionäre wurden im vergangenen Jahr verwässert

ADDvise Group AB (publ) Wettbewerber

Stille

OM:STIL

kr1.8b

C-Rad

OM:CRAD B

kr1.5b

Paxman

OM:PAX

kr916.4m

Surgical Science Sweden

OM:SUS

kr7.2b

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for ADDvise Group
Historical stock prices
Current Share Price	kr14.70
52 Week High	kr19.90
52 Week Low	kr9.72
Beta	0.29
1 Month Change	2.80%
3 Month Change	11.79%
1 Year Change	-19.01%
3 Year Change	208.18%
5 Year Change	1,178.26%
Change since IPO	-44.00%

Aktuelle Nachrichten und Updates

Recent updates

ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings

Feb 23

Need To Know: Analysts Are Much More Bullish On ADDvise Group AB (publ) (STO:ADDV A) Revenues

Nov 08

ADDvise Group (STO:ADDV A) Ticks All The Boxes When It Comes To Earnings Growth

Oct 21

Does ADDvise Group (STO:ADDV A) Have A Healthy Balance Sheet?

Sep 25

ADDvise Group AB (publ) Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next

Jul 26

News Flash: Analysts Just Made A Meaningful Upgrade To Their ADDvise Group AB (publ) (STO:ADDV A) Forecasts

Mar 15

Is ADDvise Group (STO:ADDV A) A Risky Investment?

Jan 24

Aktionärsrenditen

	ADDV A	SE Medical Equipment	SE Markt
7D	5.0%	-4.2%	0.1%
1Y	-19.0%	-9.7%	14.2%

Rendite im Vergleich zur Industrie: ADDV A unter dem Niveau der Branche Swedish Medical Equipment, die im vergangenen Jahr eine Rendite von -8.3% erzielte.

Rendite vs. Markt: ADDV A hinter dem Markt Swedish zurück, der im vergangenen Jahr eine Rendite von 17 erzielte.

Preisvolatilität

Is ADDV A's price volatile compared to industry and market?
ADDV A volatility
ADDV A Average Weekly Movement	5.2%
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	5.9%
10% most volatile stocks in SE Market	12.7%
10% least volatile stocks in SE Market	3.5%

Stabiler Aktienkurs: ADDV A hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: ADDV ADie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1989	620	n/a	www.addvisegroup.se

ADDvise Group AB (publ) liefert Ausrüstungen für Gesundheits- und Forschungseinrichtungen im privaten und öffentlichen Sektor in Schweden, im übrigen Europa, in Nordamerika, Afrika und Asien. Der Geschäftsbereich Lab liefert Labormöbel, Belüftung, Klima-/Reinräume und Laborausrüstung für die pharmazeutische und biowissenschaftliche Forschungsindustrie. Er ist auch an der Planung, dem Bau und der Installation von Reinräumen beteiligt.

ADDvise Group AB (publ)'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von ADDvise Group im Vergleich zum Marktanteil des Unternehmens?
ADDV A grundlegende Statistiken
Marktanteil	kr1.65b
Gewinn(TTM)	kr110.80m
Umsatz(TTM)	kr1.48b

26.4x

Kurs-Gewinn-Verhältnis

2.0x

Kurs-Umsatz-Verhältnis

Ist ADDV A zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
ADDV A Gewinn- und Verlustrechnung (TTM)
Einnahmen	kr1.48b
Kosten der Einnahmen	kr554.00m
Bruttogewinn	kr928.70m
Sonstige Ausgaben	kr817.90m
Umsatz	kr110.80m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

Jul 18, 2024

Gewinn per Aktie (EPS)	0.56
Bruttomarge	62.64%
Nettogewinnspanne	7.47%
Schulden/Eigenkapital-Verhältnis	183.3%

Wie hat sich ADDV A auf lange Sicht entwickelt?

Historische Performance und Vergleiche

ADDV A Aktienübersicht

Belohnungen

Risikoanalyse

ADDvise Group AB (publ) Wettbewerber

OM:STIL

kr1.8b

OM:CRAD B

kr1.5b

OM:PAX

kr916.4m

OM:SUS

kr7.2b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Addvise Group AB (Publ) Announces Chief Executive Officer Changes

Consensus EPS estimates fall by 30%

First quarter 2024 earnings released: EPS: kr0.22 (vs kr0.20 in 1Q 2023)

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

New minor risk - Earnings quality

Recent updates

Addvise Group AB (Publ) Announces Chief Executive Officer Changes

Consensus EPS estimates fall by 30%

First quarter 2024 earnings released: EPS: kr0.22 (vs kr0.20 in 1Q 2023)

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: kr0.56 (vs kr0.46 in FY 2022)

ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 20%

ADDvise Group AB (publ) (OM:ADDV A) acquired Axelerist, Inc. for $29.4 million.

With EPS Growth And More, ADDvise Group (STO:ADDV A) Makes An Interesting Case

Consensus EPS estimates fall by 19%, revenue upgraded

Third quarter 2023 earnings released

ADDvise Group AB (publ) to Report First Half, 2024 Results on Jul 18, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

ADDvise Group AB (publ) (OM : ADDV A) completed the acquisition of Diabetic Supply Inc.

ADDvise Group AB (publ) Announces Management Changes

Addvise Group AB (Publ) Appoints Oliver Humlen as Member of the Executive Management Team

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

New major risk - Financial position

Second quarter 2023 earnings released

Investor sentiment improves as stock rises 19%

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Innovative Endoscopy Components, L.L.C. for $11.75? million.

Here's Why ADDvise Group (STO:ADDV A) Has Caught The Eye Of Investors

Investor sentiment deteriorates as stock falls 26%

Now 32% undervalued

Investor sentiment improves as stock rises 20%

Here's Why ADDvise Group (STO:ADDV A) Can Manage Its Debt Responsibly

ADDvise Group AB (publ) (OM:ADDV A) has signed a Letter of Intent to acquire Kolplast CI S.A. for approximately BRL 210 million.

Investor sentiment improves as stock rises 17%

Is ADDvise Group AB (publ) (STO:ADDV A) Trading At A 43% Discount?

First quarter 2023 earnings released

Investor sentiment improves as stock rises 17%

Full year 2022 earnings released: EPS: kr0.45 (vs kr0.02 in FY 2021)

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire X-Ray Cassette Repair Company, Inc. for approximately $15 million.

Investor sentiment improves as stock rises 18%

Is ADDvise Group (STO:ADDV A) A Risky Investment?

ADDvise Group Appoints Fredrik Mella as Senior Vice President Alongside His Current Role as Chief Operating Officer

High number of new and inexperienced directors

Need To Know: Analysts Are Much More Bullish On ADDvise Group AB (publ) (STO:ADDV A) Revenues

ADDvise Group AB (publ) to Report Fiscal Year 2022 Final Results on Apr 05, 2023

Second quarter 2022 earnings released: EPS: kr0.11 (vs kr0.001 in 2Q 2021)

Investor sentiment improved over the past week

ADDvise Group (STO:ADDV A) Ticks All The Boxes When It Comes To Earnings Growth

ADDvise Group AB (publ), Annual General Meeting, May 05, 2023

Does ADDvise Group (STO:ADDV A) Have A Healthy Balance Sheet?

ADDvise Group AB (publ) (OM:ADDV A) entered into a letter of intent to acquire Clinichain Holding B.V. for €33.80 million.

ADDvise Group AB (publ) Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next

Second quarter 2022 earnings: Revenues exceed analyst expectations

Price target increased to kr9.25

High number of new and inexperienced directors

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Seebreath AB from the shareholders.

ADDvise Group AB (publ) Announces Executive Changes

First quarter 2022 earnings: EPS misses analyst expectations

First quarter 2022 earnings: Revenues in line with analyst expectations

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Surplus Diabetic, Inc for $19.5 million.

Erträge & Einnahmen